Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Capital Expenditures Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Capital Expenditures
-NT$21m
CAGR 3-Years
-42%
CAGR 5-Years
0%
CAGR 10-Years
16%
G
Grape King Bio Ltd
TWSE:1707
Capital Expenditures
-NT$632.6m
CAGR 3-Years
-36%
CAGR 5-Years
10%
CAGR 10-Years
-18%
Maywufa Co Ltd
TWSE:1731
Capital Expenditures
-NT$319.1m
CAGR 3-Years
-190%
CAGR 5-Years
-121%
CAGR 10-Years
-25%
Chlitina Holding Ltd
TWSE:4137
Capital Expenditures
-NT$648.8m
CAGR 3-Years
-97%
CAGR 5-Years
-5%
CAGR 10-Years
-1%

See Also

What is Maxigen Biotech Inc's Capital Expenditures?
Capital Expenditures
-21m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Capital Expenditures amounts to -21m TWD.

What is Maxigen Biotech Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
16%

Over the last year, the Capital Expenditures growth was -41%. The average annual Capital Expenditures growth rates for Maxigen Biotech Inc have been -42% over the past three years , and 16% over the past ten years .

Back to Top